If you build developer tools, the default script is seductive: ship a hosted SaaS, charge per seat, grow with word of mouth, and let the cloud bill scale with usage. Then you talk to a hospital, a pharma team, or a research lab, and the script quietly breaks. They cannot send their data to your servers. Not because they are behind the times — because the data legally or contractually cannot leave the building. For a builder, that constraint looks like a wall. Handled well, it is closer to a moat.
This is a note on what I have learned pricing and positioning a tool for exactly those buyers, where on-premise deployment is the feature, not the limitation.
The market is hiding in plain sight
The instinct is to assume regulated buyers are a niche. The storage numbers suggest otherwise. Komprise, surveying enterprise NAS environments, found that 60% to 70% of data had not been opened in over 90 days, yet it was still parked on the most expensive primary storage tier. That is an enormous volume of cold, paid-for, rarely-read material — and in hospitals it shows up as imaging archives and document piles that grow faster than anyone curates them.
Now layer the productivity case on top. A knowledge-management comparison found that employees without a formal knowledge program spend about 8.5 hours a week searching for information; with one, that falls to 4.6 hours. The 3.9 hours reclaimed per person per week works out to roughly 98 full-time equivalents freed per 1,000 employees. For a 2,000-person hospital system, that is nearly 200 people's worth of time recovered. That is the ROI story a CFO will actually read.
So the addressable problem is large, measurable, and paid for by people who already feel the pain. The catch is that the buyer cannot use the easy version of your product.
Local-first is the differentiator, not the compromise
Most tools treat on-premise as a grudging enterprise edition bolted on later. For regulated industries, flip that. Make "runs entirely on your infrastructure, nothing leaves the network" the headline, because for these buyers it is the edition most likely to clear procurement. A competitor who only offers SaaS is not a competitor here — they are disqualified before the demo. That is the moat: the thing that makes your product harder to build is the thing that makes it one of the few paths these buyers can actually take.
The flip side is real. Local-first raises your support and packaging burden. You ship an artifact that must install cleanly on operating systems you do not control, including domestic environments some hospitals standardize on. But that burden is a barrier to entry for everyone else too, which is precisely the point.
Pricing models that survive procurement
Per-seat SaaS pricing maps poorly onto a buyer whose real unit is the corpus, not the headcount. A hospital might have fifty people who touch the tool and fifty thousand documents that need taming. A few models I have seen work better:
- Per-corpus or per-terabyte. You price the thing being processed, not the people processing it. It aligns with the Komprise reality — the pain scales with data volume, not logins.
- Tiered by deployment shape. A single-site on-prem license, a multi-site license, an air-gapped license. Each step reflects real delivery cost and real buyer willingness to pay.
- Outcome-anchored pilots. Because the ROI is quantifiable (those 3.9 hours and 98 FTE per 1,000), a pilot that measures reclaimed search time lets you charge against proven value rather than speculation.
What tends not to work is forcing a monthly per-seat meter on an air-gapped install that has no phone home. If the environment cannot report usage, your pricing cannot depend on metering it. Design the commercial model for the constraint, not against it.
Distribution lessons from a walled market
Regulated buyers do not discover tools the way SaaS buyers do. They buy through integrators, through existing hospital IT vendors, and through reference accounts a procurement officer already trusts. A few things that moved the needle more than a launch:
- Referenceable outcomes beat feature lists. One hospital that recovered search time is worth more than a polished landing page.
- Interoperability is distribution. If your tool drops into the stack a hospital already runs — their storage, their OS, their identity system — the existing vendor becomes a channel.
- Compliance documentation is marketing. A clear data-residency and masking writeup does the selling that a billboard cannot, because it is what their security review actually reads.
The support tax you should price in
Local-first means you inherit the buyer's environment, and environments vary. Budget for an install that must survive unusual operating systems, restricted networks, and a security team that wants to read every line of your deployment docs. That load is real, and underpricing it is the fastest way to lose money on an otherwise solid account. The flip side is stickiness: a tool correctly installed inside a hospital network is painful to rip out, which is another quiet advantage over a SaaS someone can cancel in a click.
The evaluation framework buyers quietly use
When a regulated buyer compares options, they are not scoring "which AI is smartest." They are scoring fit. The dimensions below are the ones I see appear again and again:
| Dimension to evaluate | What the buyer checks |
|---|---|
| Data residency and exit rules | Does any data leave their network, and what regulations bind it? |
| Sensitive-field handling | How many categories of personal or health information can it detect and mask before use? |
| Format coverage | Do their real file types — scans, images, Office, OFD, DICOM — work without conversion? |
| Volume reduction | What is the typical size reduction, and does it preserve what humans need to read? |
| Cost at scale | Processing and storage cost as the corpus grows into the millions of pages. |
| Auditability | Are ingestion, masking, and access logged for their compliance review? |
| Deployment fit | On-prem, air-gapped, and compatible with the operating systems they already run? |
Notice none of that is "which model wins." For this buyer, model quality is table stakes. The decision is made on the rows above. More of these engineering notes live on the blog.
What I would tell a fellow builder
If you are eyeing regulated industries, the temptation is to wait until your tool is "enterprise ready." Resist that. The local-first constraint is the product strategy, not a future milestone. Build the on-prem, no-egress version first, price it against the data rather than the seats, and let integrators carry it into accounts you will never reach directly.
The market is large, the buyers are sticky, and the competition that cannot meet the residency bar has already eliminated itself. That is not a limitation you are stuck with. It is the edge you get to keep.
Try it now
To see how an on-premise, no-egress pipeline handles regulated document workloads, visit the UglyPear Data site for the RAG data engineering base, or review SmartSlim for compression. More engineering notes and cases are on the blog.
FAQ
Q: Why do regulated buyers reject SaaS so quickly?
A: It is rarely a preference. Their data is bound by residency and exit rules, so a hosted option is disqualified before evaluation. Local-first is the edition that can clear procurement.
Q: What pricing model fits an air-gapped install?
A: Per-seat metering fails when the environment cannot report usage. Per-corpus or flat annual licensing tracks the actual work and survives an offline install.
Q: Does local-first mean higher support cost?
A: Yes, you inherit the buyer's environment — unusual operating systems, restricted networks, strict security review. Pricing that burden in, because underpricing it is the fast route to losing money on a good account.
Q: How do you reach regulated buyers without a self-serve funnel?
A: Through integrators, existing IT vendors, and reference accounts. A clear data-residency and masking writeup does more selling than a landing page, because it is what their security review actually reads.
Q: Is the local-first constraint a disadvantage?
A: It is the opposite. The work that makes your product harder to build is the same work that disqualifies competitors who only offer SaaS — which is the moat.